About Us
ACADIA Pharmaceuticals is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders.
More »
News
December 07, 2011
ACADIA Pharmaceuticals to Present at the Oppenheimer 22nd Annual Healthcare Conference on December 14, 2011
November 09, 2011
ACADIA Pharmaceuticals Reports Third Quarter 2011 Financial Results
Product Candidates
Our clinical pipeline consists of four product candidates including pimavanserin, which is in Phase III development as a treatment for Parkinson's disease psychosis. In addition, we have a product candidate in Phase II development for chronic pain, a product candidate in Phase I development for glaucoma, and AM-831 in Phase I development for schizophrenia. More »
Company Information
 |
Request Information » |
 |
Investor Webcasts » |  |
Email Updates » |